F
Fabiana K. Ludka
Researcher at Universidade Federal de Santa Catarina
Publications - 22
Citations - 594
Fabiana K. Ludka is an academic researcher from Universidade Federal de Santa Catarina. The author has contributed to research in topics: Neuroprotection & Excitotoxicity. The author has an hindex of 12, co-authored 22 publications receiving 478 citations.
Papers
More filters
Journal ArticleDOI
Guanosine controls inflammatory pathways to afford neuroprotection of hippocampal slices under oxygen and glucose deprivation conditions
Tharine Dal-Cim,Fabiana K. Ludka,Wagner C. Martins,Charlise Reginato,Esther Parada,Javier Egea,Manuela G. López,Carla I. Tasca +7 more
TL;DR: GUO affords neuroprotection of hippocampal slices subjected to OGD by a mechanism that implicates the following: prevention of mitochondrial membrane depolarization, reduction of oxidative stress, regulation of inflammation by inhibition of nuclear factor kappa B and inducible nitric oxide synthase, and promoting glutamate uptake.
Journal ArticleDOI
Acute atorvastatin treatment exerts antidepressant-like effect in mice via the l-arginine–nitric oxide–cyclic guanosine monophosphate pathway and increases BDNF levels
Fabiana K. Ludka,Andréa D.E. Zomkowski,Mauricio P. Cunha,Tharine Dal-Cim,Ana Lúcia Bertarello Zeni,Ana Lúcia S. Rodrigues,Carla I. Tasca +6 more
TL;DR: It is demonstrated that atorvastatin exerts an antidepressant-like effect and point to dependence on the inhibition of NMDA receptors and NO-cGMP synthesis, and on the increase of hippocampal BDNF levels.
Journal ArticleDOI
Involvement of PI3K/Akt/GSK-3β and mTOR in the antidepressant-like effect of atorvastatin in mice.
Fabiana K. Ludka,Leandra C. Constantino,Tharine Dal-Cim,Luisa Bandeira Binder,Andréa D.E. Zomkowski,Ana Lúcia S. Rodrigues,Carla I. Tasca +6 more
TL;DR: Results suggest an involvement of the PI3K/Akt/GSK-3β/mTOR signaling pathway in the antidepressant-like effect of atorvastatin in mice.
Journal ArticleDOI
Involvement of PI3K/Akt Signaling Pathway and Its Downstream Intracellular Targets in the Antidepressant-Like Effect of Creatine.
Mauricio P. Cunha,Josiane Budni,Josiane Budni,Fabiana K. Ludka,Francis L. Pazini,Julia M. Rosa,Ágatha Oliveira,Mark William Lopes,Carla I. Tasca,Rodrigo B. Leal,Ana Lúcia S. Rodrigues +10 more
TL;DR: The results indicate that the antidepressant-like effect of creatine in the TST depends on the activation of Akt, Nrf2/HO-1, GPx, and mTOR, and GSK3 inhibition.
Journal ArticleDOI
Both creatine and its product phosphocreatine reduce oxidative stress and afford neuroprotection in an in vitro Parkinson's model.
Mauricio P. Cunha,Mauricio P. Cunha,Maria Dolores Martin-de-Saavedra,Maria Dolores Martin-de-Saavedra,Alejandro Romero,Alejandro Romero,Javier Egea,Fabiana K. Ludka,Carla I. Tasca,Marcelo Farina,Ana Lúcia S. Rodrigues,Manuela G. López +11 more
TL;DR: Investigating the neuroprotective effect of creatine and PCr against 6-hydroxydopamine (6-OHDA)-induced mitochondrial dysfunction and cell death in rat striatal slices found they minimize oxidative stress in striatum to afford neuroprotection of dopaminergic neurons.